Skip to content

To see the effect of allergens associated respiratory symptoms in COPD patients

Effect of Allergic Phenotype on Respiratory Sypmtoms And Exacerbations in Patients With Chronic Obstructive Pulmonary Disease - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075591
Enrollment
50
Registered
2024-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Skin Prick test and Absolutel Eosinophil count and Serum IgE and Spirometry and Chest Xray in Suspected Allergic COPD Patients: 15 month Control Intervention1: Nil: Nil Control Interv

Sponsors

Government Medical College Bhavnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with FEVI/FVC less than 70% post bronchodilator irreversibility, diagnosed as COPD on the basis of spirometry , radiological profile(bilateral hyperinflated lung) will be considered. Patients between 30 to 70 years of age group Patients ready to give informed consent for inclusion in the study and skin prick test.

Exclusion criteria

Exclusion criteria: Patient on oral glucocorticosteroids greater than 4weeks in 6 month duration Patients having history of dermatography. Patients on immunosuppresive medication,patients on monoclonal antibodies like omalizumab,patient on immunoglobulin therapy and patient taking anti histaminic drugs. Patient with past history of severe allergic reactions and anaphylaxis. Patient having active tuberculosis infection. Pregnant women.

Design outcomes

Primary

MeasureTime frame
To estimate prevalance of sensitivity to various allergens through absolute eosinophil count , Serum IgE and skin prick test in patients of COPD To assess correlation between allergen positivity and various respiratory symptoms in COPD patients Timepoint: 15 months

Secondary

MeasureTime frame
To assess gender wise prevalence of sensitivity to various allergens. To study various aspect of patient profile like occupation, family history, medications usedTimepoint: 15 monthd

Countries

India

Contacts

Public ContactDr Jigna Trivedi

Government medical college,bhavnagar

drjignadave@yahoo.co.in9825096289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026